Levophed(r) Norepinephrine Bitartrate Injection, Solution, Concentrate
Product Images NDC 51662-1315

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Levophed(r) Norepinephrine Bitartrate (NDC 51662-1315). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pouch Label (51662131527 Levophed Pouch Label)

LEVOPHED® NOREPINEPHRINE BITARTRATE INJECTION 4mg/4mL is a potent drug used for IV infusion only. This package contains 4mL of solution with an expiration date of 2030-09-30 and lot number 300930. The drug should be protected from light and should not be given without medical supervision. It also contains sulfites and should be stored at a temperature between 20 to 25°C (68 to 77°F) with permissible excursions to 15 to 30°C (59 to 86°F). The package insert should be read carefully before use. The manufacturer is HF Acquisition Co., LLC located in Mukilteo, WA, with original NDC: 0409-3375-04. This medication is labeled for prescription use only.*

FDA Label Image

Case Labeling (51662131534 Levophed Case Label)

LEVOPHED ® NOREPINEPHRINE BITARTRATE is an injection, with a concentration of 4mg/4mL, that comes in a 4mL vial box of 10. Its lot number is 12345 and its expiration date is September 30, 2050. This drug is potent, and patients should not be left unattended during administration. It is for IV infusion only and should be protected from light, as it contains sulfites. It should be stored at 20 to 25°C (68 to 77°F), with excursions permitted to 15 to 30°C (59 to 86°F). This product's package insert should be read carefully. The original manufacturer's NDC is 0409-3375-04. This product should be used by prescription only and was manufactured by HF Acquisition Co., LLC in Mukilteo, Washington.*

FDA Label Image

Rfid Label (51662131534 Levophed Rfid Label)

FDA Label Image

How Supplied (How Supplied)

This is a medication packaging for a product with NDC code 0409-3375-04, containing 4mg/4mL of the medication. The unit of sale concentration of this medication is not specified. The product is sold in a carton containing 10 units and each unit has 1mg/mL concentration of the medication.*

FDA Label Image

Logo (Logo)

FDA Label Image

Carton (Levophed 0409 3375 14 Carton)

This is a description of Levophed, a drug for intravenous infusion that contains norepinephrine bitartrate, equivalent to 1mg norepinephrine base, sodium chloride and sodium metabisulfite as an antioxidant. The dosage should be controlled by frequent determination of blood pressure, and the solution should not be used if it is pinkish or darker than slightly yellow or contains a precipitate. The drug should be protected from light, and discarding the unused portion is advised.*

FDA Label Image

Vial (Levophed 0409 3375 14)

This text represents a prescription drug called evophed or norepinephrine bitartrate injection, with a concentration of 4mg/4mL. It comes in a single-dose flip-top vial with a volume of 4mL to be filled into a 5mL vial. It is designed for intravenous infusion only and should be used with care as it contains Sulfites. The drug is distributed by Hospira, Inc. located in Lake Forest, IL, USA.*

FDA Label Image

Precautions (Precautions)

The text is a medical guideline on how to treat extravasation ischemia, which can cause sloughing and necrosis. The recommended solution is to infiltrate the affected area with saline solution containing 5-10mg of Regitine, an adrenergic blocking agent. Using a fine hypodermic needle, the solution should be infiltrated throughout the affected area, which is identified by its cold, hard, and pallid appearance. If administered within 12 hours, the treatment causes immediate and noticeable local hyperemic changes. Early administration is recommended to prevent further complications.*

FDA Label Image

Serialized Label (Serialized Label)

FDA Label Image

Structure (Structure)

FDA Label Image

Vial Label (Vial Label)

This text describes a medication called Levophed. It is contained in a single dose flip-top vial, with 4 mL of the medication in a 5 mL vial. The medication is for intravenous infusion only and contains sulfites. The medication is norepinephrine bitartrate injection, USP 4 mg/4mL (1 mg/mL). There is a warning that the medication contains sulfites. The NDC number for the medication is 0409-3375-04, and it is manufactured by Hospira, Inc. in Lake Forest, IL 60045 USA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.